Insider Trading Activity Sorrento Therapeutics Inc (NASDAQ:SRNE) – Major Shareholder Sold 150,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Sorrento Therapeutics Inc (NASDAQ:SRNE)

Abg Management Ltd , Major Shareholder of Sorrento Therapeutics Inc (NASDAQ:SRNE) reportedly Sold 150,000 shares of the company’s stock at an average price of 7.19 for a total transaction amount of $1,078,500.00 SEC Form

Insider Trading History For Sorrento Therapeutics Inc (NASDAQ:SRNE)

  • On 11/7/2013 Opko Health, Inc., Major Shareholder, sold 120,380 with an average share price of $9.03 per share and the total transaction amounting to $1,087,031.40.
  • On 11/8/2013 Opko Health, Inc., Major Shareholder, sold 2,000 with an average share price of $8.75 per share and the total transaction amounting to $17,500.00.
  • On 11/13/2013 Opko Health, Inc., Major Shareholder, sold 13,457 with an average share price of $8.75 per share and the total transaction amounting to $117,748.75.
  • On 11/14/2013 Opko Health, Inc., Major Shareholder, sold 1,900 with an average share price of $8.75 per share and the total transaction amounting to $16,625.00.
  • On 11/15/2013 Opko Health, Inc., Major Shareholder, sold 2,710 with an average share price of $8.75 per share and the total transaction amounting to $23,712.50.
  • On 11/19/2013 Jaisim Shah, Director, bought 1,000 with an average share price of $9.00 per share and the total transaction amounting to $9,000.00.
  • On 11/19/2013 Henry Ji, CEO, bought 2,000 with an average share price of $8.59 per share and the total transaction amounting to $17,180.00.

    • Analyst Ratings History For Sorrento Therapeutics Inc (NASDAQ:SRNE)

    • On 8/12/2016 Brean Capital Reiterated Rating Buy
    • On 5/22/2017 Rodman & Renshaw Lower Price Target of rating Buy to Buy with a price target of $30.00 to $20.00
    • On 6/17/2017 FBR & Co Reiterated Rating Buy
    • On 8/3/2017 Roth Capital Initiated Coverage of rating Buy with a price target of $7.00
    • On 1/19/2018 Oppenheimer Reiterated Rating Buy with a price target of $9.00
    • On 2/1/2018 HC Wainwright Reiterated Rating Buy with a price target of $30.00

    Recent Trading Activity for Sorrento Therapeutics Inc (NASDAQ:SRNE)
    Shares of Sorrento Therapeutics Inc closed the previous trading session at 7.25 +0.00 0.00% with 7.050000190734863 shares trading hands.